_20241025122904_original_image_30.webp)
TNBC accounts for 15-20 per cent of all diagnosed breast cancers
Read More_20241001204834_original_image_1.webp)
Traditionally, treatments like chemotherapy, radiation therapy, and bone marrow transplants have been the cornerstones of blood cancer management
Read More_20240926170810_original_image_28.webp)
The congress facilitated discussions on cutting-edge advancements in cancer care, providing a platform for clinical knowledge exchange, collaboration, and innovation
Read More
Advances in precision medicine have led to the integration of targeted therapies and immunotherapy, offering promising outcomes for certain patients
Read More
Renowned oncologists presented significant findings from recent studies and trials on targeted therapies, immunotherapy treatments like Pembrolizumab, cyclin inhibitor tablets, and new surgical procedures and radiation techniques
Read More
As of 2024, the World Health Organization (WHO) estimates that over 19 million new cancer cases occur annually, with over 10 million cancer-related deaths
Read More
